Home Top Movers CELC Stock Soared Nearly 51%. What Triggered The Rise?

CELC Stock Soared Nearly 51%. What Triggered The Rise?

Starting the day at $22.08, the clinical-stage biotechnology company Celcuity Inc. (NASDAQ: CELC) watched its intraday high rise to $24.25 in last session. During Friday’s trading session, Celcuity stock also registered a low of $19.04 but concluded the day at $21.60 rising 50.94%.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

On Friday, CELC stock recorded a higher trading volume than its average daily volume in the past 30 days. Compared to the average daily volume of 288.52K, CELC stock traded on Friday for 15.8M shares. Due to a phase-1b trial for cancer treatment which provided encouraging data, the CELC stock rose on the day.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

What were the findings of the study?

Cercuity is a clinical-stage biotechnology company pursuing a comprehensive approach to companion diagnostic and therapeutic intervention for cancer patients. In form of CELsignia, CELC has created a diagnostic platform that uniquely identifies new groups of patients likely to benefit from targeted therapies using live patient tumor cells. A CELsignia CDx can help make existing targeted therapies more potent in new applications.

The preliminary data of an ongoing Phase 1b clinical trial conducted by Celcuity on 103 patients was announced on Friday.

  • The CELC clinical trial examined whether gedatolisib, a first-in-class PI3K/mTOR inhibitor, works with endocrine therapy in advanced breast cancer patients with either ER+/HER2- status.
  • CELC’s thematic study found that 53 of the 88 evaluable patients (60%) in that study exhibited an objective response by the January 11, 2021 data cut-off date.
  • Most treatment-related adverse events were of Grade 1 or 2, including those associated with Gedatolisib.
  • CELC found the two most common Grade 3 or 4 TRAEs to be stomatitis and rash associated with gedatolisib.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

CELC has achieved what?

This Phase 1b preliminary trial is showing promising results for GEDATOLISIB in patients with breast cancer. Considering the importance of addressing resistance to endocrine therapy, the CELC-researched study presented the best response rate and observed tolerability profile to date. Develop a therapeutic like gedatolisib will allow Celcuity (CELC) to more fully utilize its CELsigia platform and its cellular analysis capabilities.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why did Corvus Pharmaceuticals Inc. (CRVS) stock soar on Wednesday?

Corvus Pharmaceuticals Inc. (CRVS) shares surged 9.17% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $2.38. in the regular...

Havertys Furniture Companies Inc. (HVT) stock gains during after-hour trading, Here’s to know why?

Havertys Furniture Companies Inc. (NASDAQ: HVT) stock declined by 0.39% at last close whereas the HVT stock price gains by 4.6% in the after-hours...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Why did Corvus Pharmaceuticals Inc. (CRVS) stock soar on Wednesday?

Corvus Pharmaceuticals Inc. (CRVS) shares surged 9.17% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $2.38. in the regular...

Antero Resources Corp. (AR) stock fell during after-market. Here’s to know why?

Antero Resources Corp. (NASDAQ: AR) stock plunged by 0.58% at last close while the AR stock price declines by 6.59% in the after-hours trading...

Why Electrameccanica Vehicles Corp. (SOLO) stock performed well on Wednesday?

Electrameccanica Vehicles Corp. (SOLO) shares gained 5.71% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $3.70 per share. in...

Related News

Why Electrameccanica Vehicles Corp. (SOLO) stock performed well on Wednesday?

Electrameccanica Vehicles Corp. (SOLO) shares gained 5.71% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $3.70 per share. in...

Encore Wire Corporation Inc. (WIRE) stock surges during current market. Here’s to know why?

Encore Wire Corporation Inc. (NASDAQ: WIRE) stock gained by 11.10% in the current market trading session. Encore Wire Corporation is a prominent manufacturer of...

Why Futu Holdings Limited (FUTU) stock is surging in pre-market on Wednesday?

Futu Holdings Limited (FUTU) shares surged 7.56% in pre-market on Wednesday, July 28, 2021, as of this writing. Yesterday in the after-hours session, FUTU's...

Mattel Inc. (MAT) stock surged during pre-market trading, post financial results announcement

Mattel Inc. (NASDAQ: MAT) stock declined by 1.2% at the last close whereas the MAT stock price rises by 5.26% in the pre-market trading...

Here is why Juniper Networks Inc. (JNPR) stock plunged in the after-markets on Tuesday?

Juniper Networks Inc. (JNPR) shares declined 6.01% in after-hours on Tuesday, July 27, 2021, and closed the daily trading at $25.98 per share. in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam